Scribd Logo
Upload

Welcome to Scribd!

  • 77 views

    Aurosil - Issue 2

    Uploaded by

    muthu. kumar
    AUROSIL is a purified silicone oil designed for prolonged tamponade after surgical treatment for severe retinal detachment. It has a viscosity of 1000 cSt, refractive index of 1.4013-1.4053, and specific gravity of 0.967-0.975. AUROSIL provides greater stability and reduced emulsification due to its high degree of purification and low level of reactive end groups. Common adverse reactions include cataract, anterior chamber oil migration, and glaucoma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Aurosil - Issue 2

    Uploaded by

    muthu. kumar
    77 views1 page
    AUROSIL is a purified silicone oil designed for prolonged tamponade after surgical treatment for severe retinal detachment. It has a viscosity of 1000 cSt, refractive index of 1.4013-1.4053, and specific gravity of 0.967-0.975. AUROSIL provides greater stability and reduced emulsification due to its high degree of purification and low level of reactive end groups. Common adverse reactions include cataract, anterior chamber oil migration, and glaucoma.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    AUROSIL is a purified silicone oil designed for prolonged tamponade after surgical treatment for severe retinal detachment. It has a viscosity of 1000 cSt, refractive index of 1.4013-1.4053, and specific gravity of 0.967-0.975. AUROSIL provides greater stability and reduced emulsification due to its high degree of purification and low level of reactive end groups. Common adverse reactions include cataract, anterior chamber oil migration, and glaucoma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    77 views1 page

    Aurosil - Issue 2

    Uploaded by

    muthu. kumar
    AUROSIL is a purified silicone oil designed for prolonged tamponade after surgical treatment for severe retinal detachment. It has a viscosity of 1000 cSt, refractive index of 1.4013-1.4053, and specific gravity of 0.967-0.975. AUROSIL provides greater stability and reduced emulsification due to its high degree of purification and low level of reactive end groups. Common adverse reactions include cataract, anterior chamber oil migration, and glaucoma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 1

    AUROSIL

    (High Quality, Purified Silicone Oil)


    A Tamponade to treat Complex Retinal Detachments
    DESCRIPTION
    AUROSIL is fractionated, purified, sterile and apyrogenic silicone oil designed for prolonged
    tamponade after surgical treatment for severe retinal detachment.
    CHARACTERISTICS
    Viscosity (at 25°C) : 1000 cSt ±50 cSt
    Refractive index (at 25°C) : 1.4013 – 1.4053
    Specific Gravity (at 30°C) : 0.967 – 0.975
    Average Molecular Weight (daltons) : 44,000 ±1000
    Poly Dispersion Index : 2.5
    Toxic Residue : Nil
    Content of -OH-end groups : <70 ppm
    INDICATIONS
    Retinal detachment with giant tear, retinal detachment with proliferative vitreo retinopathy
    (PVR), proliferative diabetic retinopathy (PDR) and traumatic retinal detachment.
    CONTRAINDICATION
    Pseudophakic patients with silicone intraocular lens (silicone oil can chemically interact and
    opacify silicone elastomers).
    PRECAUTIONS
    Greater stability
    ? As with any surgical procedure, posterior segment surgery using AUROSIL presents risks
    which the surgeon must evaluate.
    Reduced emulsification due to a
    ? Do not resterilize. Single use product only. Do not use if packaging that ensures sterility is
    high degree of purification and low damaged. Do not use after expiry date.
    level of reactive -OH end groups DIRECTIONS
    In aseptic conditions decant the contents of the bottle into a sterile syringe.
    Less tissue impregnation
    ? Place the syringe in a syringe driver in order to facilitate the injection. Plug in the infusion
    terminal to the tip of the syringe. Inject slowly.
    Subject to all physical and
    ?
    During withdrawal, avoid leaving silicone bubbles in the vitreo-retinal cavity.
    chemical analysis (H-NMR
    Once AUROSIL is removed from the patient's eye it should be treated as any human
    spectral test, gel permeation
    biological product.
    chromatography study and
    gas chromatography) to ensure ADVERSE REACTIONS
    purity level The most common adverse reactions include cataract, anterior chamber oil migration,
    keratopathy and glaucoma. Other adverse reactions include optic nerve atrophy,
    Low level of catalyst impurities
    ? rubeosis iritis, temporary IOP increase, macular pucker, vitreous hemorrhage, phthisis,
    minimize the risks of interactions traction detachment, angle block, subretinal strands, retinal rupture, endophthalmitis,
    with the ocular environment subretinal silicone oil, choroidal detachment, aniridia and cystoid macular edema.
    Opacification of silicone IOL has been reported (in-vitro).
    Quality product with a proven
    ?
    ADMIXTURE INCOMPATIBILITY
    track record Do not admix with any other substance prior to injection
    STORAGE
    Store between 2ºC and 35ºC.
    0197
    SUPPLY
    10 ml vial in a sterile pouch

    Information published in this catalogue is subject to change without notification


    Issue 2 - 08/10

    aurolab
    Excellence . . . in sight
    No 1, Sivagangai Main Road, Veerapanjan, Madurai 625 020, India.
    Phone: 91 452 2446100 Fax: 91 452 2446200
    E-mail: [email protected] Web: www.aurolab.com

    A R A V I N D E Y E C A R E S Y S T E M

    You might also like